Physician profile
Tara E Morris
NPI 1013950674
$7,063.72
in general payments reported to CMS, 2019-2025
44 companies · $1,772 in 2025
The $1,772 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $870 · 2022: $1,272 · 2023: $1,619 · 2024: $1,531 · 2025: $1,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,851 · Education: $70.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,850.55 |
| Education | $70.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $922.62 | 2021-2025 | Tysabri, Vumerity, Avonex |
| Emd Serono, INC. | $799.38 | 2022-2025 | Mavenclad |
| Ucb, INC. | $538.24 | 2021-2025 | Rystiggo, Briviact, Zilbrysq |
| Horizon Therapeutics Plc | $448.30 | 2021-2023 | Uplizna |
| Novartis Pharmaceuticals Corporation | $344.91 | 2021-2025 | |
| Abbvie INC. | $336.38 | 2021-2025 | |
| Amgen INC. | $306.22 | 2022-2025 | Uplizna |
| Lundbeck LLC | $305.00 | 2022-2025 | Vyepti, Rexulti |
| Neurelis, INC. | $269.22 | 2021-2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $269.21 | 2021-2025 | Ultomiris, Soliris |
| Sk Life Science, INC. | $238.37 | 2022-2025 | |
| Lilly USA, LLC | $216.60 | 2021-2025 | Emgality |
| Csl Behring | $211.40 | 2021-2025 | Hizentra |
| Genentech USA, INC. | $202.72 | 2022-2025 | Ocrevus, Ocrevus Zunovo |
| Argenx US, INC. | $159.15 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.